Strata Critical Medical Inc. Class A Common Stock (SRTA)
Stock · NASDAQ · Health Care
$4.54as of 10/16/2026
Price chart
SRTA Signal Track Record
How signals performed across all stocks →What SRTA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | -2.9% | 43% | October 1, 2026 |
| Bollinger Band Breakout | 25 | -2.4% | 48% | August 4, 2026 |
| 200-Day Moving Average TouchActive now | 21 | +0.9% | 52% | September 10, 2026 |
| Bollinger Band Breakdown | 16 | -7.6% | 25% | September 29, 2026 |
| Any 20-session window (baseline) | -1.3% | 48% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SRTA
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery proced…
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- Employees
- 327
- Website
- stratacritical.com/
Fundamentals
- 1-day range
- $4.5$4.7
- Market cap
- $494.53M
- P/E (trailing)
- 9.58
- P/E (forward)
- —
- EPS (trailing)
- $0.49
- Dividend yield
- —
- Beta
- 2.58
- Avg. volume
- 930.7K
How Strata Critical Medical Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 3, 2026 · via SEC EDGAR / Finnhub
Forecasts
4 analyst ratings
Strata Critical Medical Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- SRTAStrata Critical Medical Inc. Class A Common Stock$4.54▲ 4.61%Market cap $494.53MP/E 9.58$3.95$6.5
- STLNStarling Oncology Inc. Common Stock$6.43▼ 7.02%Market cap $498.91MP/E —$4.85$7.13
- AUNAAuna SA Class A Ordinary Shares$5.32▲ 0.38%Market cap $384.87MP/E 83.35$4.09$6.71
- AIRSAirSculpt Technologies Inc. Common Stock$1.27▼ 9.89%Market cap $336.50MP/E —$1.41$12
- SBCSBC Medical Group Holdings Incorporated Common Stock$5.16▼ 2.64%Market cap $305.46MP/E 11.12$2.78$5.61
- AHCOAdaptHealth Corp. Common Stock$6.02▼ 5.79%Market cap $824.20MP/E —$5.21$13.43
- LFMDLifeMD Inc. Common Stock$2.34▼ 4.88%Market cap $164.43MP/E 589.89$2.36$6.53
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SRTA Strata Critical Medical Inc. Class A Common Stock | $494.53M | 9.58 | $4.54 | ▲ 4.61% | $3.95$6.5 |
| STLN Starling Oncology Inc. Common Stock | $498.91M | — | $6.43 | ▼ 7.02% | $4.85$7.13 |
| AUNA Auna SA Class A Ordinary Shares | $384.87M | 83.35 | $5.32 | ▲ 0.38% | $4.09$6.71 |
| AIRS AirSculpt Technologies Inc. Common Stock | $336.50M | — | $1.27 | ▼ 9.89% | $1.41$12 |
| SBC SBC Medical Group Holdings Incorporated Common Stock | $305.46M | 11.12 | $5.16 | ▼ 2.64% | $2.78$5.61 |
| AHCO AdaptHealth Corp. Common Stock | $824.20M | — | $6.02 | ▼ 5.79% | $5.21$13.43 |
| LFMD LifeMD Inc. Common Stock | $164.43M | 589.89 | $2.34 | ▼ 4.88% | $2.36$6.53 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Third Point Says Acquired Strata Critical Medical's Securities For Investment Purposes And Believe That Common Stock Is "Undervalued"benzinga · 10/15/2026
- Surf Air Mobility: Aviation Cash Burn Is Outpacing The Software StorySeekingAlpha · 10/5/2026
- Prediction: The Next Big Aviation Revolution Could Start With JobyYahoo · 10/1/2026
- Strata Critical Medical Q2 2026 Earnings Call TranscriptBenzinga · 9/28/2026
- Strata Critical Medical: Pivot To M&A Offers Near-Term Upside, But TAM Constraints RemainSeekingAlpha · 9/16/2026
Insider Activity
Insider Actions →- Tomkiel Melissa M. · September 24, 2026 · Tax Withholding90.8K @ $5.27
- Tomkiel Melissa M. · September 24, 2026 · Grant177.9K
- Heyburn William A. · September 24, 2026 · Tax Withholding98.4K @ $5.27
- Heyburn William A. · September 24, 2026 · Grant177.9K
- Verdetto Louis R. · September 8, 2026 · Tax Withholding5.7K @ $5.31
- Wunsch Scott M · September 8, 2026 · Tax Withholding5.7K @ $5.31
- Cohen Amir · September 8, 2026 · Tax Withholding4.6K @ $5.31
- Tomkiel Melissa M. · September 8, 2026 · Tax Withholding29.7K @ $5.31
- Heyburn William A. · September 8, 2026 · Tax Withholding31.7K @ $5.31
- Love Reginald · August 10, 2026 · Sale5.1K @ $5.75
- Wunsch Scott M · July 31, 2026 · Tax Withholding14.0K @ $5.09
- Heyburn William A. · July 31, 2026 · Tax Withholding199.2K @ $5.09
- Tomkiel Melissa M. · July 31, 2026 · Tax Withholding212.3K @ $5.09
- Cohen Amir · July 31, 2026 · Tax Withholding34.0K @ $5.09
- Wunsch Scott M · July 30, 2026 · Grant57.2K
Institutional Ownership
March 31, 2026
- Total shares held
- 54.90M
- Total value held
- $228.91M
- Institutional holders
- 122
- Unknown7.46M
- Unknown5.00M
- Unknown4.57M
- Unknown4.09M
- Unknown2.87M
- Unknown2.82M
- Unknown2.82M
- Unknown2.60M
- Unknown2.27M
- Unknown1.70M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Strata Critical Medical Releases Q2 2026 Earnings Call Transcript
Strata Critical Medical released the transcript of its Q2 2026 earnings call. The discussion covers revenue, operating expenses, and guidance for the next quarter. The release gives investors a clearer view of the company’s financial performance and outlook, which may affect trading near its support level.
Strata Critical Medical Releases Q2 2026 Earnings Call Transcript. Strata Critical Medical released the transcript of its Q2 2026 earnings call. The discussion covers revenue, operating expenses, and guidance for the next quarter. The release gives investors a clearer view of the company’s financial performance and outlook, which may affect trading near its support level.